Antitumor effect of Escozul™ from a medical perspective
Are there Scientific Publications confirming its Antitumor Effect and Mechanism of Action?
Why is the LifEscozul™ Method the most efficient?
What are the results of treatment with Escozul™ (LifEscozul™) in oncology patients?
What does it mean that Escozul™ selectively eliminates malignant cells?
Does it really have these wonderful anti-cancer properties?
Are there scientific publications that support its antitumor effect?
These are some of the questions we receive from oncologists and the general public who consult us about Escozul™.
In this article we will briefly explain the effect of treatment with Escozul™ (LifEscozul™) in patients with different types of cancer and which scientific studies demonstrate its effectiveness.
SCIENTIFIC PUBLICATIONS CONFIRMING ITS ANTITUMOR EFFECT AND MECHANISM OF ACTION
STUDIES CARRIED OUT BY DOCTOR ALEXIS DÍAZ ON BLUE SCORPION VENOM (ESCOZUL™)
In the analysis of the Blue Scorpion Venom (Escozul™) and its properties, we are going to focus on the scientific evidence and its significance for cancer patients.
In 2013 Dr. Alexis Diaz, together with other scientists, published an article entitled: In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines.
To date, this is the first article indicating the use of the active principle of the Blue Scorpion Venom in cancer cell lines.
In this study it was concluded that:
"R. junceus venom induces a selective and differential anticancer effect against epithelial cancer cells...To our knowledge, this is the first scientific evidence demonstrating the effect on cell viability and cell death events of this scorpion venom in a panel of human cancer cell lines. This makes R. junceus venom a favorable candidate for future studies in in vivo antitumor experiments."
In the article In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines, also published in 2019 by Dr. Alexis Diaz and other experts, it was evidenced that:
"Scorpion venom induced significant inhibition of tumor progression in F3II (murine mammary adenocarcinoma) bearing mice in a dose-dependent manner."
Murine mammary tumor virus is a virus discovered more than 50 years ago as a milk-borne entity that induces mammary carcinomas in the patient.
Then we have the latest article published by Dr. Alexis Diaz and other specialists in Frontiers Magazine in June 2020: Voltage-Gated K + / Na + Channels and Scorpion Venom Toxins in Cancer, which describes that:
"Likewise, in vivo toxicological studies have been performed , using R. junceusvenene administered intraperitoneally (10 mg / kg) or orally (2,000 mg / kg), and no toxic effects were observed...In addition, breast tumor-bearing mice injected intraperitoneally with ten consecutive doses of R. junceusvenene (3.2 mg / kg), showed reduced tumor progression and a reduction of tumor markers Ki67 and CD31, confirming its anticancer potential."
All these scientific studies show that Blue Scorpion Venom is a potent anticarcinogen and that it does not produce side effects in the body.
LIFESCOZUL™ METHOD: FROM BLUE SCORPION VENOM TO LIFESCOZUL™ TREATMENT
For the Blue Scorpion Venom to be effective in the treatment of cancer patients, a series of phases must be fulfilled, since the unprocessed venom mixed with water ("artisanal" method) does not cause any effect on the patient.
That is why the LifEscozul™ Method, created by our Scientific Team led by Dr. Alexis Diaz, is the safest and most effective, thus our LifEscozul™ treatment was born.
Our method is as follows:
Venom Extraction: taking all biosafety measures we "milk" the scorpion to extract its venom.
Microbiological Control: in this way we rule out that the venom sample has bacteria.
Venom Processing: we extract the active ingredient and determine the protein concentration.
Protein Concentration: we determine the protein concentration.
Dose Determination: each patient receives a personalized and unique dose according to his/her disease.
Preservatives: we add preservatives so that the active ingredient does not lose its properties.
Shelf life: the formulation must be kept refrigerated to prevent it from decomposing and damaging its properties.
If you wish to learn more about the LifEscozul™ Method, we invite you to read our article: Differences between the LifEscozul™ Method and the Artisanal Method.
RESULTS OF TREATMENT WITH ESCOZUL™ (LIFESCOZUL™) IN THE MOST RELEVANT PATIENTS
Throughout our more than 17 years of research and scientific studies on Blue Scorpion Venom (Escozul™), we have been able to prove the anti-tumor effect of treatment with Escozul™ (LifEscozul™) in different types of cancer and in patients of different ages, stages and health conditions.
With rigorous treatment with Escozul™ (LifEscozul™), in some cases combined with conventional therapies, our patients have shown a significant reduction of metastases and primary tumors.
In this sense, we would like to name some of the most outstanding cases to explain this antitumor effect:
Miguel Canali, Lung Cancer: in July 2018 Miguel undergoes a PET Scan and it was reported that there was a mass of 8.27 x 6.28 centimeters in his left lung, moreover it was locally advanced because it involved local nodes. By February 2019 Miguel was only on treatment with Escozul™ (LifEscozul™), and by March 2019 he underwent a CT scan and the presence of cancer in the lung was no longer visible.
Jorge Padilla, Pancreatic Cancer: in March 2019 Jorge is diagnosed with Pancreatic Cancer, and the tumor of approximately 2.5 x 2.9 centimeters surrounded the superior mesenteric artery. Jorge was on chemotherapy until November 2019 and then only took LifEscozul™ to treat his disease. By August 2020 his doctors confirmed that there was no longer a tumor and the artery was completely healthy with no cancer cells.
Isabella Lopez, Anaplastic Astrocytoma (Brain Cancer): in April 2011 Isabella was diagnosed with a grade 3 Anaplastic Astrocytoma (a brain tumor located in the center of her nervous system). She was only predicted to have 6 months to live and her mother, Yensy, decided to start with our treatment in May 2011. From that moment until today Isabella has only been treated with Escozul™ (LifEscozul™), and according to her reports the tumor measures less than 12 millimeters.
Natalia Ferreyra, Breast Cancer: in August 2017 Natalia was diagnosed with Breast Cancer (the tumor measured 2 centimeters) with metastasis to the liver. In February 2018 she presented multiple lesions in both hepatic lobes, the largest of 32 millimeters and lesions of 15 millimeters in D11 and D6. In April 2018 she started with LifEscozul™ treatment and by August 2018, only taking our treatment, the presence of the tumor was no longer observed in the left breast nor in D6.
Matías Hoyos, Pineoblastoma: when he was only 3 years old Matías had a tumor recurrence despite having received conventional therapies, so his doctors did not offer him more treatment options and sent him home. His mother did not give up and decided to start LifEscozul™ treatment in July 2019. To date, Matias is cancer free.
Cecilia Ochoa, Triple Negative Infiltrating Ductal Carcinoma: when Cecilia was diagnosed in January 2020, the mass in her left breast measured 7 centimeters. Due to the aggressiveness of her disease, she was not expected to have long to live. In February 2020 she started with our LifEscozul™ treatment combined with chemotherapy sessions (of which she has had no side effects), and by September 2020 there was no tumor residue.
Enrique Arrascue, Medulloblastoma Grade IV: this type of tumors are very aggressive, and in April 2018, after receiving radiotherapy and chemotherapy and suffering many sequelae due to side effects, Enrique had a recurrence of the disease. In January 2019 he started with LifEscozul™ treatment, and by March 2020 Enrique reported that there was no longer cancer present.escozul/dia-internacional-de-la-lucha-contra-el-cancer/" target="_blank" rel="noopener">cáncer.
Raúl Galarza, Prostate Cancer: before starting with our treatment Raúl presented metastasis in bone and liver (it is not common for Prostate Cancer to metastasize in this way), and the tumor measured 6 centimeters. In October 2019 he started LifEscozul™ and combined it with chemotherapy sessions. By September 2020 his doctors were surprised because there were no traces of the tumor and the metastases had shrunk, he had also regained weight and suffered no side effects from the chemotherapy.
Hector Nahoul, Bladder Cancer: in his case Mr. Hector decided to take only LifEscozul™ to treat his disease. His disease was progressing very fast, so he started with our treatment in November 2019. At that time Mr. Hector had multiple lesions in his bladder, and 4 months later his exams revealed that there were only the presence of 2 nodules of no more than 11 millimeters. With the LifEscozul™ treatment we were able to stop the progression of the disease.
Rosa Gonzalez, Esophageal Cancer: in July 2019 an endoscopy revealed a 3 centimeter tumor in the esophagus, and by that time there was metastasis to the lymph nodes. At the beginning of our treatment, in September 2019, Rosa could not swallow food or liquids, but this situation changed after only one month of taking LifEscozul™ combined with chemotherapy and radiotherapy sessions. By October 2020 there was no longer the presence of cancer.
Additionally, our patients have also presented the following effects thanks to our treatment:
- Increased appetite: thanks to this effect patients gain weight, in addition our nutritional medical accompaniment helps them to have a healthy diet.
- Mobility of upper and lower limbs: in some cases, patients cannot move their arms and legs due to the symptoms of the disease, but with LifEscozul™ treatment, after a few months they are able to get out of bed without help.
- Sleep: patients recover normal sleep functions.
- Pain: pain decreases to the point that patients are able to resume their daily activities.
Thanks to all these registered effects, our patients have been able to recover their quality of life.
For more information we invite you to visit our Most Recent Results section.
In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines Alexis Díaz-García, Luis Morier-Díaz, Yahima Frión-Herrera, Hermis Rodríguez-Sánchez, Yamira Caballero-Lorenzo, Dianeya Mendoza-Llanes, Yanelis Riquenes-Garlobo, José A Fraga-Castro, J Venom Res. 2013; 4: 5-12. Published online 2013 Jun 12. PMCID: PMC3717326.
Diaz Garcia, Alexis & Ruiz-Fuentes, Jenny & Herrera, Yahima & Yglesias, Arianna & Garlobo, Yanelis & Sanchez, Hermis & Aurrecochea, Juan & Fuentes, Ledys. (2019). Rhopalurus junceus scorpion venom induces antitumor effect in vitro and in vivo against a murine mammary adenocarcinoma model. Iranian Journal of Basic Medical Science. 22. 759-765. 10.22038/ijbms.2019.33308.7956.
Díaz-García A and Varela D (2020) Voltage-Gated K+/Na+ Channels and Scorpion Venom Toxins in Cancer. Front. Pharmacol. 11:913. doi: 10.3389/fphar.2020.00913.
We are the LifEscozul™ Group and Results Define Us.